Furthermore, our in vitro and ex vivo experiments revealed that the treatment of KCs with H.ECMTM liposome promoted the mRNA expression of HAS3 and AQP3, the factors influencing skin hydration. The gene discussed is HAS3; the disease is dry eye syndrome.